2017
Helsinn Group supports Satellite Symposium at 10th International Conference on Cachexia, Sarcopenia and Muscle Wasting
APR’s Physiomimic Technology for inherited metabolic diseases
Helsinn Announces Attendance at the CPhI 2017 Conference in Frankfurt
Helsinn Pharmaceuticals (Beijing) Co. Ltd. Opens Office in Shanghai, China
Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO)
MICRO-SPHERE ENLISTS GERMAN EXPERTISE TO BOOST CAPSULE FILLING CAPABILITIES
RIVOPHARM acquires multi product baskets of TEVA’s Divestment
Helsinn Group supports prIME’s Satellite Symposium at ESMO 2017
Helsinn Group Announces Upcoming Presentation of Phase III data of NEPA (fosnetupitant/ palonosetron) IV at ESMO 2017
Progetto Talenti
Linkedin